A succinct summary of the evidence-base for Slenyto® (paediatric prolonged-release melatonin) for the treatment of insomnia in children and adolescents with Autistic Spectrum Disorder and/ or Smith-Magenis Syndrome
To request further information on the Therapeutic Bulletin, please contact us.